The New York Times 2004 Barnaby J. Feder - Abstracts

The New York Times 2004 Barnaby J. Feder
TitleSubjectAuthors
Criticism of Drug May Leave Pfizer Awash in Lawsuits.(Business/Financial Desk)(PFIZER AND CELEBREX: THE COMPANY)News, opinion and commentaryBarnaby J. Feder
Doctors Use Nanotechnology to Improve Health Care.(Business/Financial Desk)(TECHNOLOGY)News, opinion and commentaryBarnaby J. Feder
Even as Insurers Balk, Surgeons in U.S. Start Implanting Artificial Disks.(Business/Financial Desk)(An Alternative to Spinal Fusion)News, opinion and commentaryBarnaby J. Feder
Johnson & Johnson Decides It Needs Devices.(Business/Financial Desk)(THE MARKETS: MARKET PLACE)News, opinion and commentaryBarnaby J. Feder
Johnson Said To Be in Talks For Heart Device Maker.(Business/Financial Desk)News, opinion and commentaryAndrew Ross Sorkin, Barnaby J. Feder
KPMG Units Agree to Pay To Settle Malpractice Suits.(Business/Financial Desk)News, opinion and commentaryBarnaby J. Feder
Latest MyDoom Worm Plagues Search Sites.(Business/Financial Desk)News, opinion and commentaryBarnaby J. Feder
Lawyers Organizing for Mass Suits Over Vioxx.(Business/Financial Desk)News, opinion and commentaryBarnaby J. Feder
New Chief to Take Reins as Motorola Takes on Challenge of Rivals.(Business/Financial Desk)News, opinion and commentaryBarnaby J. Feder
One Stent Maker Thrives as Rival Gets the Kudos.(Business/Financial Desk)News, opinion and commentaryBarnaby J. Feder
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.